Cargando…

The Great I-QALY Disaster

The QALY is an impossible construct; it defies common sense. It fails completely once we consider the axioms of fundamental measurement. Utilities as ordinal scales cannot be used to create QALYS. The QALY should never have been introduced to support the value assessment of pharmaceutical products a...

Descripción completa

Detalles Bibliográficos
Autor principal: Langley, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075148/
https://www.ncbi.nlm.nih.gov/pubmed/34007635
http://dx.doi.org/10.24926/iip.v11i3.3359
_version_ 1783684487862812672
author Langley, Paul C.
author_facet Langley, Paul C.
author_sort Langley, Paul C.
collection PubMed
description The QALY is an impossible construct; it defies common sense. It fails completely once we consider the axioms of fundamental measurement. Utilities as ordinal scales cannot be used to create QALYS. The QALY should never have been introduced to support the value assessment of pharmaceutical products and devices. The result is 30 years of QALY based assessments of pharmaceutical products and devices which are conceptually and technically wrong. They are a charade and will have contributed mistakenly to thousands of formulary decisions. In the search for a common metric to evaluate cost-effectiveness the impossibility of a QALY was overlooked. The result is a disaster, unfolding over decades. Our next steps must be to abandon the QALY paradigm and look ahead to a new value assessment framework.
format Online
Article
Text
id pubmed-8075148
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-80751482021-05-17 The Great I-QALY Disaster Langley, Paul C. Innov Pharm Commentary The QALY is an impossible construct; it defies common sense. It fails completely once we consider the axioms of fundamental measurement. Utilities as ordinal scales cannot be used to create QALYS. The QALY should never have been introduced to support the value assessment of pharmaceutical products and devices. The result is 30 years of QALY based assessments of pharmaceutical products and devices which are conceptually and technically wrong. They are a charade and will have contributed mistakenly to thousands of formulary decisions. In the search for a common metric to evaluate cost-effectiveness the impossibility of a QALY was overlooked. The result is a disaster, unfolding over decades. Our next steps must be to abandon the QALY paradigm and look ahead to a new value assessment framework. University of Minnesota Libraries Publishing 2020-07-31 /pmc/articles/PMC8075148/ /pubmed/34007635 http://dx.doi.org/10.24926/iip.v11i3.3359 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Langley, Paul C.
The Great I-QALY Disaster
title The Great I-QALY Disaster
title_full The Great I-QALY Disaster
title_fullStr The Great I-QALY Disaster
title_full_unstemmed The Great I-QALY Disaster
title_short The Great I-QALY Disaster
title_sort great i-qaly disaster
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075148/
https://www.ncbi.nlm.nih.gov/pubmed/34007635
http://dx.doi.org/10.24926/iip.v11i3.3359
work_keys_str_mv AT langleypaulc thegreatiqalydisaster
AT langleypaulc greatiqalydisaster